🔎 Trials Near Me

Home › Sakit sa Coronary Artery › West Virginia

Pag-aaral pangklinika para sa Sakit sa Coronary Artery sa West Virginia

7 pag-aaral para sa Sakit sa Coronary Artery ang naghahanap ng mga kalahok sa mga site sa West Virginia.

Mga Lungsod sa West Virginia

Opisyal na teksto ng pag-aaral (English)

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • Nephrology and Hypertension Associates, Bluefield
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05485961

Product Surveillance Registry

  • Morgantown
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Set 18, 2026 · NCT01524276

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

  • Charleston Area Medical Center, Charleston
Nagre-recruit
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT07258290

Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

  • Charleston Area Medical Center, Charleston
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 24, 2026 · NCT06779630

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

  • Huntington VA Medical Center, Huntington, WV, Huntington
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 17, 2025 · NCT02915198

MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

  • West Virginia University Heart & Vascular Institute, Morgantown
Nagre-recruit
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 11, 2025 · NCT06271590

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

  • West Virginia University and Vascular Institute, Morgantown
Nagre-recruit
Edad 18 hanggang 110 · Lahat ng kasarian · Na-update Peb 25, 2025 · NCT05908331

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.